TE_6076
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 366.31 |
| Counts of samples | TCGA_tumor:324; TCGA_normal:0; GTEx:0 |
| TSS | chr2(-):147727390 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_6076.21 | - | Intergenic | Non-coding | Non-coding | chr2(-):147578254,147578274,147675511,147675577,147727264,147727391 |
| teRNA_6076.22 | - | Intergenic | Non-coding | Non-coding | chr2(-):147608863,147608883,147675511,147675577,147727264,147727391 |
| teRNA_6076.23 | - | Intergenic | Non-coding | Non-coding | chr2(-):147391975,147391995,147675511,147675577,147727264,147727391 |
| teRNA_6076.24 | - | Intergenic | Non-coding | Non-coding | chr2(-):147671328,147671348,147675511,147675577,147727264,147727391 |
| teRNA_6076.25 | - | Intergenic | Non-coding | Non-coding | chr2(-):147674485,147674505,147675511,147675577,147727264,147727391 |
| teRNA_6076.26 | - | Intergenic | Non-coding | Non-coding | chr2(-):147675557,147675577,147726997,147727391 |
| teRNA_6076.27 | - | Intergenic | Non-coding | Non-coding | chr2(-):147578254,147578274,147675511,147675577,147726997,147727391 |
| teRNA_6076.28 | - | Intergenic | Non-coding | Non-coding | chr2(-):147578254,147578274,147675511,147675577,147726997,147727118,147727264,147727391 |
| teRNA_6076.29 | - | Intergenic | Non-coding | Non-coding | chr2(-):147578254,147578274,147675511,147675577,147677254,147677322,147727001,147727118,147727264,147727391 |
| teRNA_6076.30 | - | Intergenic | Non-coding | Non-coding | chr2(-):147578254,147578274,147675511,147675577,147677254,147677322,147726997,147727118,147727264,147727391 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
